Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 24 | $32,151,862 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 30 Jan 2025 12:03 | APLS | Apellis Pharmaceuticals Inc | FRANCOIS CEDRIC | Chief Executive Officer | 29 Jan 2025 | Sale | 2,824 | 29.5236 | 83,375 | D |
| 23 Jan 2025 15:28 | APLS | Apellis Pharmaceuticals Inc | FRANCOIS CEDRIC | Chief Executive Officer | 22 Jan 2025 | Sale | 13,551 | 30.4255 | 412,296 | D |
| 21 Jan 2025 16:04 | APLS | Apellis Pharmaceuticals Inc | FRANCOIS CEDRIC | Chief Executive Officer | 17 Jan 2025 | Sale | 6,007 | 29.9582 | 179,959 | D |
| 14 Jan 2025 16:18 | APLS | Apellis Pharmaceuticals Inc | FRANCOIS CEDRIC | Chief Executive Officer | 13 Jan 2025 | Sale | 6,247 | 28.7021 | 179,302 | D |
| 05 Mar 2024 16:07 | APLS | Apellis Pharmaceuticals Inc | FRANCOIS CEDRIC | Chief Executive Officer | 01 Mar 2024 | Sale | 413 | 65.68 | 27,126 | D |
| 05 Mar 2024 16:07 | APLS | Apellis Pharmaceuticals Inc | FRANCOIS CEDRIC | Chief Executive Officer | 01 Mar 2024 | Sale | 116,512 | 64.9163 | 7,563,528 | D |
| 05 Mar 2024 16:07 | APLS | Apellis Pharmaceuticals Inc | FRANCOIS CEDRIC | Chief Executive Officer | 01 Mar 2024 | Sale | 41,704 | 62.9631 | 2,625,813 | D |
| 05 Mar 2024 16:07 | APLS | Apellis Pharmaceuticals Inc | FRANCOIS CEDRIC | Chief Executive Officer | 01 Mar 2024 | Sale | 62,503 | 64.2573 | 4,016,274 | D |
| 05 Mar 2024 16:07 | APLS | Apellis Pharmaceuticals Inc | FRANCOIS CEDRIC | Chief Executive Officer | 01 Mar 2024 | Sale | 28,868 | 62.213 | 1,795,965 | D |
| 13 Feb 2024 16:49 | APLS | Apellis Pharmaceuticals Inc | FRANCOIS CEDRIC | Chief Executive Officer | 12 Feb 2024 | Sale | 3,962 | 67.7669 | 268,492 | D |
| 31 Jan 2024 16:26 | APLS | Apellis Pharmaceuticals Inc | FRANCOIS CEDRIC | Chief Executive Officer | 29 Jan 2024 | Sale | 2,843 | 64.1382 | 182,345 | D |
| 23 Jan 2024 19:28 | APLS | Apellis Pharmaceuticals Inc | FRANCOIS CEDRIC | Chief Executive Officer | 22 Jan 2024 | Sale | 13,431 | 64.996 | 872,961 | D |
| 17 Jan 2024 16:32 | APLS | Apellis Pharmaceuticals Inc | FRANCOIS CEDRIC | Chief Executive Officer | 16 Jan 2024 | Sale | 7,851 | 66.8086 | 524,514 | D |
| 21 Nov 2023 17:36 | APLS | Apellis Pharmaceuticals Inc | FRANCOIS CEDRIC | Chief Executive Officer | 21 Nov 2023 | Sale | 5,000 | 48.8 | 244,000 | D |
| 01 Sep 2023 16:05 | APLS | Apellis Pharmaceuticals Inc | FRANCOIS CEDRIC | Chief Executive Officer | 01 Sep 2023 | Sale | 10,284 | 42.44 | 436,453 | D |
| 01 Sep 2023 16:05 | APLS | Apellis Pharmaceuticals Inc | FRANCOIS CEDRIC | Chief Executive Officer | 01 Sep 2023 | Sale | 139,716 | 41.7025 | 5,826,506 | D |
| 18 May 2023 17:10 | APLS | Apellis Pharmaceuticals Inc | FRANCOIS CEDRIC | Chief Executive Officer | 16 May 2023 | Sale | 2,120 | 87.6739 | 185,869 | D |
| 18 May 2023 17:10 | APLS | Apellis Pharmaceuticals Inc | FRANCOIS CEDRIC | Chief Executive Officer | 16 May 2023 | Sale | 7,528 | 87.0163 | 655,059 | D |
| 18 May 2023 17:10 | APLS | Apellis Pharmaceuticals Inc | FRANCOIS CEDRIC | Chief Executive Officer | 16 May 2023 | Sale | 3,007 | 85.9012 | 258,305 | D |
| 18 May 2023 17:10 | APLS | Apellis Pharmaceuticals Inc | FRANCOIS CEDRIC | Chief Executive Officer | 16 May 2023 | Sale | 14,611 | 85.0089 | 1,242,065 | D |
| 18 May 2023 17:10 | APLS | Apellis Pharmaceuticals Inc | FRANCOIS CEDRIC | Chief Executive Officer | 16 May 2023 | Sale | 1,800 | 83.845 | 150,921 | D |
| 18 May 2023 17:10 | APLS | Apellis Pharmaceuticals Inc | FRANCOIS CEDRIC | Chief Executive Officer | 16 May 2023 | Sale | 934 | 83.1711 | 77,682 | D |
| 20 Apr 2023 16:51 | APLS | Apellis Pharmaceuticals Inc | FRANCOIS CEDRIC | Chief Executive Officer | 18 Apr 2023 | Sale | 30,000 | 82.024 | 2,460,720 | D |
| 23 Mar 2023 16:55 | APLS | Apellis Pharmaceuticals Inc | FRANCOIS CEDRIC | Chief Executive Officer | 21 Mar 2023 | Sale | 30,000 | 62.7444 | 1,882,332 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)